Skip to main content
IFF logo

IFF · International Flavors & Fragrances Inc

Track IFF — free
$83.92 +0.66 (+0.79%) At close · Oct 6
Market Cap
$21.86B
Shares
255.15M
Volume · Oct 6 1.84M Avg daily vol (3M) 1.69M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$83.92 Open$84.01 Day$83.51–84.62 52W close$59.55–88.07 Avg vol 30d1.7M Short int16.3M · 6.4% float · 10.6d Short vol60% Last earningsAug 5, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 4

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 4 wks
filed Aug 4, 2026
call held Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$10.82B
Trailing 12 months
Net income (TTM)
$279.00M
Trailing 12 months
Revenue growth YoY
+1.8%
Year over year
Operating margin
7.5%
Trailing 12 months
P / E (TTM)
75.7
Trailing earnings · reciprocal yield 1.3%
FCF yield
2.5%
TTM · current market cap
Return on invested capital
3.2%
Trailing 12 months
Net cash
−$5.13B
Latest balance sheet
Dividend yield
1.9%
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
+33.9%
Trailing year
Short interest
6.4%
Latest settlement · 10.6 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. IFF posted strong Q2 results on a continuing-operations basis with 6% comparable currency-neutral sales and EBITDA growth, raised the low end of its full-year 2026 sales and EBITDA guidance ranges, and announced a $2.5B share repurchase program alongside the planned $3.8B Food Ingredients divestiture to CVC Capital Partners, while flagging ~$100M of stranded costs and Middle East volatility as risks.

Bullish
  • + Raised low end of FY2026 EBITDA guidance to 4%-8% growth
  • + Q2 comparable currency-neutral sales grew 6% with broad-based volume growth across Taste, Scent, and H&B
  • + Free cash flow up $284M YoY to $378M in H1 2026
  • + Announced $2.5B share repurchase program with $500M accelerated in H2 2026, signaling confidence in valuation
Bearish
  • − ~$100M of stranded corporate costs temporarily pressure segment margins post Food Ingredients divestiture
  • − Working capital headwinds of ~$200M expected in H2 2026 from Food Ingredients separation

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bearish Fundamentals Fair Quant / Vol Moderate
Market backdrop VIX 15 · calm Equity put/call 0.57
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +10%
above
Price vs 50-day avg −0%
below
RSI (14) 48
neutral
MACD trend Negative
52-week position 85%
near high
Momentum
relative strength
Very Strong
1-month return −2%
trailing
6-month return +17%
trailing
YTD return +25%
this year
Relative strength +6%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $84 › 200d $77 — 50d above 200d
Institutional flow Distributing
10 of 760 funds reported for Sep 30 · net -186.9K sh shares
Insider flow Distributing
Net -$1.3M over 90 days · 100% sells
Short interest Rising
6.39% of float · ▲ +1.0% MoM · 10.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
760 holders — mid 3-yr range
Squeeze score 68
elevated · 0–100
Fundamentals
Fair
Revenue growth −5%
Y/Y
Gross margin 36%
expanding
EPS growth −236%
Y/Y
Free cash flow $256.0M
Valuation P/E 77.9
rich
Buyback $400.0M
remaining
Balance sheet $5.4B
net debt
Quant / Vol
risk profile
Moderate
Volatility 36%
annualized · 1-yr
Max drawdown −20%
past year
ATR 2.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 3
Latest guidance · from the 8-K filed Aug 4, 2026
Sales · full year 2026 Initiated $7.4B – $7.6B
prior FY $10.89B midpoint −31.1% Y/Y
Adjusted operating EBITDA · full year 2026 Non-GAAP Initiated $1.53B – $1.6B
Comparable currency neutral sales growth · full year 2026 Non-GAAP Initiated 2% – 4%
Comparable currency neutral adjusted operating EBITDA growth · full year 2026 Non-GAAP Initiated 4% – 8%
Guided vs delivered · last 3 settled
Full year 2023 sales guidance range full year 2023
guided $11.3B – $11.6B
$11.48B In line
Revenue fiscal year 2022
guided $12.3B – $12.7B
$12.44B In line
Total revenue full-year 2021
guided $11.55B
$11.66B Beat +0.9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+10% Bullish
Price vs 50-day avg
−0% Neutral
RSI (14)
48 Neutral
MACD trend
Negative Bearish
52-week position
85% Bullish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $84 › 200d $77 — 50d above 200d
Institutional flow Distributing
10 of 760 funds reported for Sep 30 · net -186.9K sh shares
Insider flow Distributing
Net -$1.3M over 90 days · 100% sells
Short interest Rising
6.39% of float · ▲ +1.0% MoM · 10.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
760 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $60 Now $84 · 85% Range high $88
vs 200-day avg +10% vs 50-day avg 0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IFF
International Flavors & Fragrances Inc
this stock
$21.86B +24.5% -5.2% 77.9 6.4%
LIN
Linde PLC
$216.61B +14.9% +3.0% 30.3 1.3%
AIQUF
L Air Liquide SA /Fi
$121.25B +1.5% — — 0.0%
SHW
Sherwin Williams Co
$79.89B -0.9% +2.1% 30.4 2.6%
ECL
Ecolab Inc.
$77.67B +7.0% +2.2% 37.2 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
760
% held
106.8%
Reported
10 of 760
Top holder
Dodge & Cox
Held Float
View
Held by Funds
Fund positions
680
View
Short & Settlement
Short Interest Rising
Shares short
16.3M
Days to cover
10.6d
Change
+155.1K sh
View
Short Volume
Short vol %
60%
As of
Oct 6, 2026
Short Total
View
Fails to Deliver
FTD shares
2.1K
Value
$175.0K
As of
Sep 11, 2026
View
Off-Exchange
Off-exchange %
36.5%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$1.3M
Buyers / Sellers
0 / 3
Buyers Sellers
View
Congressional Trades Buy
Member
Gilbert Cisneros
Amount
$1.0K–$15.0K
Traded
Nov 18, 2025
View
Financials
Financials
Revenue (FY)
$10.9B
Net income (FY)
$339.8M
EPS diluted
$-1.41
View
Buybacks
Authorized · 3 programs
$5.0B
Remaining
$400.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 4, 2026
This year
12
View
Proposed Sales
Value
$475.7K
Shares
5.7K
Filed
Aug 17, 2026
View
Earnings & Events
Webcasts
Last webcast
Aug 5, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
IFF -1.6% -2.0% +17.3% +0.5% +24.5%
SPY +2.0% +1.7% +11.3% +2.2% +14.3%
vs SPY -3.5% -3.7% +6.0% -1.6% +10.3%

Capital returns

Latest dividend
$0.40 / share · ex Sep 18, 2026
Cut 50.6%
Paid (TTM)
$1.60 / share · 4 payouts
Dividend yield (TTM, derived)
1.91%
Buyback programs · 3 active · as of Aug 4, 2026
Authorized (total)
$5.00B
Spent (derived)
$4.60B
Remaining
$400.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 51253 CUSIP 459506101 13F (30d) 25 filings 20 filers Visit website Investor relations